PATENT CLAIM ANALYSIS

Application Number: 16007742
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-12
Patent Classification: ["514", "016600"]

Abstract:
The present invention provides an isolated or recombinant protein consisting of the amino acid sequence according to SEQ ID NO: 3 or SEQ ID: NO: 4 and its use in the prevention or treatment of an inflammatory condition.

Claim (Index 10):
The method according to  claim 9 , wherein the inflammatory condition is selected from rheumatoid arthritis, psoriatic arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, rejection of an organ, skin, tissue, blood, serum, plasma, or cell transplant, and inflammatory bowel disease.

Metadata:
- Claim Count in Document: 43.0
- Percentile: 94.0
- Lexical Diversity: 1.3125
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11911056', '12019567', '14411047', '10218547', '10466136']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7797479465383484
- 35 USC 102 Novelty (BERT): 0.52061040841165
- Combined Prediction Score: 0.7538341927256786
- Mean Citation Score: 268.664458
- Max Citation Score: 304.61853
- Similarity Product: 201.72264948384228

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test